The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses

被引:0
作者
Pitchers, Kieran G. [1 ]
Boakye, Oliver D. [2 ]
Campeotto, Ivan [2 ]
Daly, Janet M. [1 ]
机构
[1] Univ Nottingham, Sch Vet Med & Sci, One Virol, Loughborough LE12 5RD, Notts, England
[2] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Notts, England
来源
PATHOGENS | 2024年 / 13卷 / 06期
基金
英国生物技术与生命科学研究理事会;
关键词
African horse sickness; virus-like particle; recombinant plant expression; Orbivirus; live attenuated vaccine; EPIZOOTIC HEMORRHAGIC-DISEASE; BLUETONGUE VIRUS; HORSESICKNESS VIRUS; IMMUNE-RESPONSE; PROTEIN; IMMUNOGENICITY; VACCINATION; EXPRESSION; PROTECTION; STRAINS;
D O I
10.3390/pathogens13060458
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
African horse sickness is a devastating viral disease of equids. It is transmitted by biting midges of the genus Culicoides with mortalities reaching over 90% in na & iuml;ve horses. It is endemic to sub-Saharan Africa and is seasonally endemic in many parts of southern Africa. However, outbreaks in Europe and Asia have occurred that caused significant economic issues. There are attenuated vaccines available for control of the virus but concerns regarding the safety and efficacy means that alternatives are sought. One promising alternative is the use of virus-like particles in vaccine preparations, which have the potential to be safer and more efficacious as vaccines against African horse sickness. These particles are best made in a complex, eukaryotic system, but due to technical challenges, this may cause significant economic strain on the developing countries most affected by the disease. Therefore, this review also summarises the success so far, and potential, of recombinant protein expression in plants to reduce the economic strain of production.
引用
收藏
页数:16
相关论文
共 108 条
[1]   Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge [J].
Alberca, Berta ;
Bachanek-Bankowska, Katarzyna ;
Cabana, Marta ;
Calvo-Pinilla, Eva ;
Viaplana, Elisenda ;
Frost, Lorraine ;
Gubbins, Simon ;
Urniza, Alicia ;
Mertens, Peter ;
Castillo-Olivares, Javier .
VACCINE, 2014, 32 (29) :3670-3674
[2]  
[Anonymous], FAO Stock of Horses in South Africa from 2010 to 2021
[3]   Ecological niche modeling predicting the potential distribution of African horse sickness virus from 2020 to 2060 [J].
Assefa, Ayalew ;
Tibebu, Abebe ;
Bihon, Amare ;
Dagnachew, Alemu ;
Muktar, Yimer .
SCIENTIFIC REPORTS, 2022, 12 (01)
[4]   Peruvian horse sickness virus and Yunnan orbivirus, isolated from vertebrates and mosquitoes in Peru and Australia [J].
Attoui, Houssam ;
Rosario Mendez-Lopez, Maria ;
Rao, Shujing ;
Hurtado-Alendes, Ana ;
Lizaraso-Caparo, Frank ;
Jaafar, Fauziah Mohd ;
Samuel, Alan R. ;
Belhouchet, Mourad ;
Pritchard, Lindsay I. ;
Melville, Lorna ;
Weir, Richard P. ;
Hyatt, Alex D. ;
Davis, Steven S. ;
Lunt, Ross ;
Calisher, Charles H. ;
Tesh, Robert B. ;
Fujita, Ricardo ;
Mertens, Peter P. C. .
VIROLOGY, 2009, 394 (02) :298-310
[5]  
BARNARD BJH, 1994, ONDERSTEPOORT J VET, V61, P391
[6]  
Barnard BJH, 1998, ARCH VIROL, P13
[7]  
Boinas F., 2009, EFSA Support. Publ, V6, p4E, DOI [10.2903/sp.efsa.2009.EN-4, DOI 10.2903/SP.EFSA.2009.EN-4]
[8]   GROWTH OF AFRICAN HORSE-SICKNESS VIRUS IN EMBRYONATED HEN EGGS AND TRANSMISSION OF VIRUS BY CULICOIDES-VARIIPENNIS COQUILLETT (DIPTERA, CERATOPOGONIDAE) [J].
BOORMAN, J ;
MELLOR, PS ;
PENN, M ;
JENNINGS, M .
ARCHIVES OF VIROLOGY, 1975, 47 (04) :343-349
[9]   African horse sickness virus NS4 is a nucleocytoplasmic protein that localizes to PML nuclear bodies [J].
Boughan, Shareen ;
Potgieter, A. Christiaan ;
van Staden, Vida .
JOURNAL OF GENERAL VIROLOGY, 2020, 101 (04) :366-384
[10]   CHARACTERIZATION AND CLONING OF THE AFRICAN HORSESICKNESS VIRUS GENOME [J].
BREMER, CW ;
HUISMANS, H ;
VANDIJK, AA .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :793-799